A photoactivatable theranostic probe for simultaneous oxidative stress-triggered multi-color cellular imaging and

Xiaohui Chen1, Zicong Zhang2, Wenshuai Luo3

  • 1Center for AIE Research, Shenzhen Key Laboratory of Polymer Science and Technology, Guangdong Research Center for Interfacial Engineering of Functional Materials, College of Materials Science and Engineering, Shenzhen University, Shenzhen, 518060, China; Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, College of Physics and Optoelectronic Engineering, Shenzhen University, Shenzhen, 518060, China.

Biomaterials
|July 25, 2022
PubMed

Insights

Researchers developed a novel photoactivatable fluorescent probe for real-time monitoring of oxidative stress in cancer cells. This probe enables simultaneous imaging and photodynamic therapy, effectively inhibiting tumor growth.

Area of Science:

  • Biomedical Engineering
  • Chemical Biology
  • Cancer Research

Background:

  • Simultaneous in situ monitoring of organelles during oxidative stress and therapeutic interventions remain challenging.
  • Developing agents that can both image and treat oxidative stress-induced cellular damage is crucial for cancer therapy.

Purpose of the Study:

  • To design and synthesize a photoactivatable fluorescent probe (TPA-DHPy) for in situ monitoring of oxidative stress and subsequent photodynamic therapy.
  • To investigate the probe's ability to track changes in lipid droplets (LDs) and endoplasmic reticulum (ER) microenvironments.
  • To evaluate the therapeutic efficacy of the probe in inhibiting cancer cell growth.

Main Methods:

  • Synthesis of a photoactivatable fluorescent probe (TPA-DHPy) with aggregation-induced emission (AIE) properties.
  • Utilizing the probe for multi-color fluorescence imaging in lambda mode to monitor cellular microenvironments.
  • Employing type I/type II photosensitization for reactive oxygen species generation and photodynamic therapy under white light irradiation.

Main Results:

  • The probe TPA-DHPy transforms into TPA-Py, exhibiting polarity sensitivity and red-shifted emission, enabling sensitive imaging.
  • Successful in situ monitoring of lipid droplets (LDs) and endoplasmic reticulum (ER) alterations under oxidative stress.
  • Demonstrated effective photodynamic therapy by TPA-Py, leading to the destruction of LDs and ER functions and significant tumor growth inhibition.

Conclusions:

  • The developed theranostic agent offers a novel approach for imaging-guided precise cancer therapy.
  • The probe facilitates simultaneous monitoring and treatment of oxidative stress-related cellular damage.
  • This study provides insights for designing next-generation theranostic agents for cancer treatment.

Related Concept Videos